# Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

> **NCT00998270** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 185 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Autologous bone marrow transplantation
- **PROCEDURE:** Allogeneic bone marrow transplantation

## Key facts

- **NCT ID:** NCT00998270
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2014-10
- **Final completion:** 2017-10
- **Target enrollment:** 185 (ESTIMATED)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998270, "Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00998270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*